Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.

MLA

Singh, Sudershan, et al. “Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 52, no. 3, Feb. 2011, pp. 387–95. EBSCOhost, https://doi.org/10.1093/cid/ciq111.

APA

Singh, S., Willig, J. H., Mugavero, M. J., Crane, P. K., Harrington, R. D., Knopp, R. H., Kosel, B. W., Saag, M. S., Kitahata, M. M., & Crane, H. M. (2011). Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 52(3), 387–395. https://doi.org/10.1093/cid/ciq111

Chicago

Singh, Sudershan, James H Willig, Michael J Mugavero, Paul K Crane, Robert D Harrington, Robert H Knopp, Bradley W Kosel, Michael S Saag, Mari M Kitahata, and Heidi M Crane. 2011. “Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 52 (3): 387–95. doi:10.1093/cid/ciq111.